Stereotaxis Shares to Begin Trading on NYSE Americ
Post# of 66
(Total Views: 355)
Posted On: 09/04/2019 4:10:14 PM
Stereotaxis Shares to Begin Trading on NYSE American Sept. 6
5:43 pm ET September 3, 2019 (Dow Jones) Print
By Stephen Nakrosis
Robotic technology company Stereotaxis (STXS) said Tuesday its common stock has been approved for listing on the NYSE American exchange.
The company's shares will begin trading on the exchange on Sept. 6 under the symbol "STXS."
Currently, the company's shares trade over-the-counter. They closed Tuesday's regular trading session with a gain of 5.06%, to finish at $2.70.
Stereotaxis has 59.3 million shares outstanding and a public float of 44.34 million shares. The company has a market cap of $152.72 million.
Stereotaxis develops robotic technology used to treat cardiac arrhythmias, it said.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 03, 2019 17:43 ET (21:43 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.
Market data and information provided by Morningstar.
Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
Information and news provided by ,, , Computrade Systems, Inc., , and
Copyright © 2019. All rights reserved.
CFRA Research Disclosure
3rd Party Research Disclosure
5:43 pm ET September 3, 2019 (Dow Jones) Print
By Stephen Nakrosis
Robotic technology company Stereotaxis (STXS) said Tuesday its common stock has been approved for listing on the NYSE American exchange.
The company's shares will begin trading on the exchange on Sept. 6 under the symbol "STXS."
Currently, the company's shares trade over-the-counter. They closed Tuesday's regular trading session with a gain of 5.06%, to finish at $2.70.
Stereotaxis has 59.3 million shares outstanding and a public float of 44.34 million shares. The company has a market cap of $152.72 million.
Stereotaxis develops robotic technology used to treat cardiac arrhythmias, it said.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 03, 2019 17:43 ET (21:43 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.
Market data and information provided by Morningstar.
Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
Information and news provided by ,, , Computrade Systems, Inc., , and
Copyright © 2019. All rights reserved.
CFRA Research Disclosure
3rd Party Research Disclosure
(0)
(0)